Medifast, Inc. — Q1 2012 Form 10-Q
Business context and period: Unaudited results for the three months ended March 31, 2012, compared with Q1 2011; balance-sheet figures are compared with December 31, 2011. Medifast sells weight-management products and services through Take Shape for Life, Medifast Direct, Weight Control Centers, and wholesale physicians. Meal products accounted for 95% of Q1 2012 revenue. Management cautions that interim results are not necessarily indicative of full-year results.
Financial performance and liquidity
| Metric | Q1 2012 | Q1 2011 / prior balance date |
|---|---|---|
| Revenue | $88.9 million | $74.3 million; up 20% |
| Gross profit / margin | $66.8 million / 75.1% | $56.7 million / 76.3% |
| SG&A | $60.6 million / 68.2% of revenue | $46.6 million / 62.7% |
| Operating income / margin | $6.1 million / 6.9% | $10.1 million / 13.6% |
| Net income / diluted EPS | $4.0 million / $0.29 | $6.4 million / $0.44 |
| Operating cash flow | $20.7 million | $18.7 million |
| Capital expenditures | $2.5 million | $3.1 million |
| Cash and cash equivalents | $31.9 million | $14.3 million at Dec. 31, 2011 |
| Investment securities | $20.1 million | $19.5 million at Dec. 31, 2011 |
| Total current assets / liabilities | $75.8 million / $27.5 million | $64.0 million / $20.3 million at Dec. 31, 2011 |
| Long-term debt and capital leases, including current portions | $6.7 million | $6.7 million at Dec. 31, 2011 |
Operating cash flow included substantial cash contributions from lower inventory and higher accounts payable and accrued expenses. Cash increased by $17.7 million during the quarter. The filing reports $4.3 million of variable-rate loans outstanding, bearing rates of 1.54%–2.24%; a 100-basis-point LIBOR increase was estimated to add $43,000 to annual interest expense.
Material changes and segment performance
- Revenue rose 20%, but net income fell 37% and operating income fell 39%. Gross margin declined 1.2 percentage points, while SG&A as a share of revenue increased 5.5 percentage points. Management attributed margin pressure to commodity and shipping costs, promotions, and higher growth-related expenses.
- Take Shape for Life revenue increased 12% to approximately $53 million; active Health Coaches were 10,200 versus 10,000, and monthly revenue per coach rose to $1,650 from $1,600.
- Medifast Direct revenue increased 19% to approximately $22.5 million. Direct-response advertising spend was approximately $7.85 million, up 15%; reported revenue-to-advertising return improved to 2.9:1 from 2.8:1.
- Weight Control Centers and Wholesale revenue increased 63% to $13.4 million. Same-store sales for corporate centers open more than one year rose 21%. The segment moved from $1.1 million pretax income to a $2.2 million pretax loss, primarily reflecting center expansion and support costs.
Outlook, management commentary, and risks
- Management expected a 2012 effective tax rate of approximately 36%–37% and anticipated opening 25–30 additional corporate Weight Control Centers during 2012. The filing provides no company-wide revenue or earnings guidance.
- In March, Medifast recorded $723,000 of restructuring charges related to eliminating or realigning approximately 70 positions. Management estimated annualized savings of approximately $3 million; a segment discussion cites approximately $2.5 million of savings for the MWCC and Wholesale segment.
- Management focused on improving center profitability through lower advertising as a share of sales, staffing changes, and more efficient corporate support, while enhancing services such as metabolic testing and dietitian support.
- Growth could strain manufacturing, warehousing, order fulfillment, call-center, and website capacity; the filing also identifies the risk of losing independent Health Coaches. Management described manufacturing capacity and warehouse systems as infrastructure priorities.
- Pending matters include securities class-action and shareholder derivative litigation, a bankruptcy trustee’s preference-payment claim against a subsidiary, and an employment-discrimination claim. The company disputes or intends to defend the claims; outcomes and potential losses are not clearly quantified. The filing also describes tax-contingency exposure that could materially affect results or cash flows if asserted successfully.
- Management concluded disclosure controls and internal control over financial reporting were effective at March 31, 2012. The filing says risk factors did not differ materially from those in the 2011 Form 10-K.
Important facts for investors to verify
- Whether center expansion can improve segment profitability after the reported $2.2 million quarterly pretax loss, and whether restructuring savings materialize.
- Whether sales growth can be sustained without further gross-margin compression or disproportionate SG&A growth.
- The cash-flow contribution from inventory reductions and increased payables, and the company’s capacity to fund planned expansion and infrastructure needs.
- The status and potential financial exposure of disclosed litigation and tax contingencies; the filing does not provide clear loss estimates.
- The repurchase authorization: 275,000 shares remained available at quarter-end, and no shares were repurchased during Q1 2012.